Clinical trial
A Double-blind, Randomised, Placebo-controlled Study of Intravenous Doses of SPL026 (DMT Fumarate), a Serotonergic Psychedelic, in Healthy Subjects (Part A) and Patients With Major Depressive Disorder (Part B)
NCT04673383 is registered in ClinicalTrials.gov with Small Pharma Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Randomised, Placebo-controlled Study of Intravenous Doses of SPL026 (DMT Fumarate), a Serotonergic Psychedelic, in Healthy Subjects (Part A) and Patients With Major Depressive Disorder (Part B)
- Lead sponsor
- Small Pharma Ltd
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- February 4, 2021
- Completion date
- December 22, 2022
- Enrollment
- 66 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.